ATM c.2859G>T ;(p.E953D)

Variant ID: 11-108141811-G-T

NM_000051.3(ATM):c.2859G>T;(p.E953D)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Lee, Kevin J KJ; Wright, Griffin G; Bryant, Hannah H; Wiggins, Leigh Ann LA; Schuler, Michele M; Gassman, Natalie R NR
Publication Date: 2020

Variant appearance in text: ATM: E953D
PubMed Link: 35582228
Variant Present in the following documents:
  • cdr-3-980.pdf
View BVdb publication page